Clinical trial
A Randomized, Blinded, Controlled Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) (Adjuvanted) in Adults Aged 18 Years and Older.
NCT07582796 is registered in ClinicalTrials.gov with Ab&B Bio-tech Co., Ltd.JS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Blinded, Controlled Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) (Adjuvanted) in Adults Aged 18 Years and Older.
- Lead sponsor
- Ab&B Bio-tech Co., Ltd.JS
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- May 14, 2026
- Completion date
- August 14, 2029
- Enrollment
- 470 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.